N-PORT filing recap · July 2023
What did ARK Genomic Revolution ETF buy in July 2023?
Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.
Stock value
$2.48B
Positions
43
Estimated turnover
9.7%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Increased positions
PACBPacific Biosciences of California, Inc.$149.27Mreported value+406.3K shares+3.7%DNAGinkgo Bioworks Holdings, Inc.$127.23Mreported value+2.79M shares+5.8%TDOCTeladoc Health, Inc.$120.61Mreported value+208.7K shares+5.4%ADPTAdaptive Biotechnologies Corporation$93.23Mreported value+2.11M shares+23.6%ACCDAccolade Inc$89.21Mreported value+197.3K shares+3.4%NTLAIntellia Therapeutics, Inc.$81.76Mreported value+71.8K shares+3.9%CDNACaredx, Inc.$75.46Mreported value+321.0K shares+4.9%TWSTTwist Bioscience Corporation$72.21Mreported value+84.0K shares+2.9%RXRXRecursion Pharmaceuticals, Inc.$71.31Mreported value+1.58M shares+45.6%ARCTArcturus Therapeutics Holdings Inc.$68.84Mreported value+41.9K shares+2.2%PATHUipath, Inc.$68.03Mreported value+803.6K shares+27.2%BEAMBeam Therapeutics Inc.$67.05Mreported value+55.0K shares+2.6%VERVVerve Therapeutics, Inc.$60.83Mreported value+228.1K shares+8.3%VCYTVeracyte, Inc.$60.35Mreported value+46.8K shares+2.2%QSIQuantum-Si Inc$57.61Mreported value+3.46M shares+30.4%TXG10x Genomics, Inc.$47.49Mreported value+16.0K shares+2.2%VEEVVeeva Systems Inc.$42.26Mreported value+4.4K shares+2.2%VRTXVertex Pharmaceuticals Inc / Ma$42.06Mreported value+2.5K shares+2.2%BFLYButterfly Network, Inc.$33.82Mreported value+279.9K shares+2.2%PRMEPrime Medicine, Inc.$33.50Mreported value+426.9K shares+23.8%SLGCUSDSomalogic Inc$32.11Mreported value+278.7K shares+2.2%MRNAModerna, Inc.$29.18Mreported value+103.5K shares+71.7%MASS908 Devices Inc.$28.54Mreported value+227.3K shares+5.9%RPTXRepare Therapeutics Inc.$24.96Mreported value+57.7K shares+2.2%REGNRegeneron Pharmaceuticals, Inc.$24.67Mreported value+700 shares+2.2%CMPSCompass Pathways Plc$23.47Mreported value+53.6K shares+2.2%GHGuardant Health, Inc.$23.16Mreported value+27.6K shares+4.9%NRIXNurix Therapeutics, Inc.$22.66Mreported value+49.6K shares+2.2%CERSCerus Corporation$20.00Mreported value+266.8K shares+4.3%PFEPfizer Inc.$17.33Mreported value+10.2K shares+2.2%PSNLPersonalis, Inc.$13.97Mreported value+232.4K shares+4.1%NVTAInvitae Corp$12.41Mreported value+634.0K shares+7.8%SNTISenti Biosciences Holdings, Inc.$1.62Mreported value+40.1K shares+2.2%BLIUSDPhenomex Inc$1.26Mreported value+48.6K shares+2.2%